参考文献/References:
[1]尹玉东,曹彬.社区获得性肺炎诊治指南解读:从病情严重度分层角度[J].中国循证医学杂志,2015,15(7):756-760.[2]Chalmers JD,Singanayagam A,Akram AR,et al.Safety and efficacy of CURB65-guided antibiotic therapy incommunity-acquired pneumonia[J].Antimicrob Chemother,2011,66(2):416-423.[3]Khawaja A,Zubairi AB,Durrani FK,et al.Etiology and outcome of severe community acquired pneumonia in immunocompetent adults[J].BMC Infect Dis,2013,94(13):1-6.[4]Lujan M,Gallego M,Fontanals D,et al.Prospective observational study of bacteremic pneumococcal pneumonia: Effect of discordant therapy on mortality[J].Crit Care Med,2004,32(3):625-31.[5]Metlay JP,Waterer GW,Long AC,et al.Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America[J].Am J Respir Crit Care Med,2019,200(7):e45-e67.[6]Lee JS,Giesler DL,Gellad WF,et al.Antibiotic Therapy for Adults Hospitalized WithCommunity-Acquired Pneumonia: A Systematic Review[J].JAMA,2016,315(6):593-602.[7]刘又宁,何礼贤.肺真菌病诊断和治疗专家共识[J].中华结核和呼吸杂志,2007,30(11):821-822.[8]Huttner B,Cappello B,Cooke G,et al.2019 Community-acquired Pneumonia Treatment Guidelines: There Is a Need for a Change toward More Parsimonious Antibiotic Use[J].Am J Respir Crit Care Med,2020,201(10):1315-1316.[9]Costantini E,Allara E,Patrucco F,et al.Adherence to guidelines for hospitalized community-acquired pneumonia over time and its impact on health outcomes and mortality[J].Intern Emerg Med,2016(11):929-940.[10]Lipinska-Gediga M,Mierzchala M,Durek G.Pro-atrial natriuretic peptide (pro-ANP) level in patients with severe sepsis and septic shock: prognostic and diagnostic significance[J].Infection,2012,40(3):303-309.[11]Self WH,Balk RA,Grijalva CG,et al.Procalcitonin as a marker of etiology in adults hospitalized with community-acquired pneumonia[J].Clin Infect Dis,2017,65(2):183-190. [12]Kamat IS,Ramachandran V,Eswaran H,et al.Low procalcitonin, community acquired pneumonia, and antibiotic therapy[J].Lancet Infect Dis,2018(18):496-497.
相似文献/References:
[1]赵建美,邵 岩.血必净治疗社区获得性肺炎的研究进展[J].医学信息,2018,31(02):20.[doi:10.3969/j.issn.1006-1959.2018.02.009]
ZHAO Jian-mei,SHAO Yan.Research Progress of Xuebijing in Treating Community Acquired Pneumonia[J].Medical Information,2018,31(17):20.[doi:10.3969/j.issn.1006-1959.2018.02.009]
[2]包克珍,许云丽.新生儿社区获得性肺炎的临床特征分析[J].医学信息,2018,31(02):184.[doi:10.3969/j.issn.1006-1959.2018.02.072]
BAO Ke-zhen,XU Yun-li.Clinical Characteristics of Neonatal Community Acquired Pneumonia[J].Medical Information,2018,31(17):184.[doi:10.3969/j.issn.1006-1959.2018.02.072]
[3]赵建美,邵 岩,李京津.电脑中频药透对治疗老年社区获得性肺炎的疗效分析[J].医学信息,2018,31(03):146.[doi:10.3969/j.issn.1006-1959.2018.03.052]
ZHAO Jian-mei,SHAO Yan,LI Jing-jin.Analysis of the Efficacy of Computer Medium Frequency Drug Penetration in the Treatment of Elderly Community-acquired Pneumonia[J].Medical Information,2018,31(17):146.[doi:10.3969/j.issn.1006-1959.2018.03.052]
[4]曹立杰,杨林瀛,于国云,等.N-末端脑钠肽前体与社区获得性肺炎患者严重程度关系研究[J].医学信息,2018,31(04):1.[doi:10.3969/j.issn.1006-1959.2018.04.001]
CAO Li-jie,YANG Lin-ying,YU Guo-yun,et al.Study on the Relationship between N-terminal Brain Natriuretic Peptide Precursors and the Severity of Community-acquired Pneumonia[J].Medical Information,2018,31(17):1.[doi:10.3969/j.issn.1006-1959.2018.04.001]
[5]赵志国.有创-无创序贯通气疗法治疗慢性阻塞性肺疾病
引发的严重呼吸衰竭的临床研究[J].医学信息,2018,31(11):110.[doi:10.3969/j.issn.1006-1959.2018.11.034]
ZHAO Zhi-guo.Clinical Study of Invasive Non-invasive Sequential Ventilation in Treatment of Severe Respiratory Failure Caused by Chronic Obstructive Pulmonary Disease[J].Medical Information,2018,31(17):110.[doi:10.3969/j.issn.1006-1959.2018.11.034]
[6]丁保锋.胃肠道恶性肿瘤患者术后肺部感染临床分析[J].医学信息,2018,31(11):183.[doi:10.3969/j.issn.1006-1959.2018.11.061]
DING Bao-feng.Clinical Analysis of Postoperative Pulmonary Infection in Patients with Malignant Gastrointestinal Cancer[J].Medical Information,2018,31(17):183.[doi:10.3969/j.issn.1006-1959.2018.11.061]
[7]俞 静,赵 红,金 晶,等.社区获得性肺炎胸部CT中反晕征的初步研究[J].医学信息,2022,35(10):109.[doi:10.3969/j.issn.1006-1959.2022.10.026]
YU Jing,ZHAO Hong,JIN Jing,et al.Preliminary Study of Reversed Halo Sign in Chest CT of Community-acquired Pneumonia[J].Medical Information,2022,35(17):109.[doi:10.3969/j.issn.1006-1959.2022.10.026]
[8]武珊珊.喜炎平注射液治疗社区获得性肺炎临床疗效的Meta分析[J].医学信息,2018,31(14):64.[doi:10.3969/j.issn.1006-1959.2018.14.020]
WU Shan-shan.Meta-analysis of Clinical Efficacy of Xiyanping Injection in the Treatment of
Community-acquired Pneumonia[J].Medical Information,2018,31(17):64.[doi:10.3969/j.issn.1006-1959.2018.14.020]
[9]徐安林,刘 忠.不同配比的哌拉西林-他唑巴坦治疗
老年性社区获得性肺炎的疗效对比[J].医学信息,2018,31(15):129.[doi:10.3969/j.issn.1006-1959.2018.15.041]
XU An-lin,LIU Zhong.Comparison of the Efficacy of Different Ratios of Piperacillin-tazobactam in Elderly Community Acquired Pneumoni[J].Medical Information,2018,31(17):129.[doi:10.3969/j.issn.1006-1959.2018.15.041]
[10]许 俊.慢性阻塞性肺疾病急性加重期与慢性阻塞性肺疾病并发社区获得性肺炎患者的临床对比[J].医学信息,2018,31(22):118.[doi:10.3969/j.issn.1006-1959.2018.22.033]
XU Jun.Clinical Comparison of Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease and Chronic Obstructive Pulmonary Disease Complicated with Community Acquired Pneumonia[J].Medical Information,2018,31(17):118.[doi:10.3969/j.issn.1006-1959.2018.22.033]